← All peptidesGLP-1 / Metabolic
Tirzepatide
Tirzepatide (Mounjaro, Zepbound)
Dual GIP/GLP-1 agonist. Stronger weight loss than semaglutide in trials.
Typical dose
2.5–15 mg
Frequency
Once weekly
Half-life
120 h
Route
subcutaneous
Typical vial sizes
10 mg20 mg30 mg60 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 8.75 mg dose
- Draw volume
- 1.750 mL
- Insulin units
- 175 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 1.1
Research notes
Titration: 2.5 → 5 → 7.5 → 10 → 12.5 → 15mg.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.